N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double-blind, placebo-controlled trial

✍ Scribed by Zhi-Wei Lai; Robert Hanczko; Eduardo Bonilla; Tiffany N. Caza; Brandon Clair; Adam Bartos; Gabriella Miklossy; John Jimah; Edward Doherty; Hajra Tily; Lisa Francis; Ricardo Garcia; Maha Dawood; Jianghong Yu; Irene Ramos; Ioana Coman; Stephen V. Faraone; Paul E. Phillips; Andras Perl

• Book ID: 115550466
• Publisher: John Wiley and Sons
• Year: 2012
• Tongue: English
• Weight: 815 KB
• Volume: 64
• Category: Article
• ISSN: 0004-3591
• DOI: 10.1002/art.34502